Literature DB >> 10782717

Depression, suicide, and suicide prevention in schizophrenia.

W S Fenton1.   

Abstract

Suicide is the single largest cause of premature death among individuals with schizophrenia. Furthermore, epidemiological data indicate that nearly 80% of patients with the diagnosis of schizophrenia will experience a major depressive episode at some time during their lifetime. This report reviews recent findings relative to the risk of suicide in schizophrenia, including data from the Chestnut Lodge longitudinal study of schizophrenia subtypes and symptom domains. Paradoxically, those patients with schizophrenia who are most likely to recover or experience a good outcome are also those at greatest risk for suicide. The reduction of morbidity and mortality in schizophrenia should include depression and suicidality as targets for both psychopharmacological and psychosocial treatment.

Entities:  

Mesh:

Year:  2000        PMID: 10782717

Source DB:  PubMed          Journal:  Suicide Life Threat Behav        ISSN: 0363-0234


  24 in total

Review 1.  Dissecting the suicide phenotype: the role of impulsive-aggressive behaviours.

Authors:  Gustavo Turecki
Journal:  J Psychiatry Neurosci       Date:  2005-11       Impact factor: 6.186

2.  Antecedents and patterns of suicide behavior in first-admission psychosis.

Authors:  Shelly Bakst; Jonathan Rabinowitz; Evelyn J Bromet
Journal:  Schizophr Bull       Date:  2009-03-09       Impact factor: 9.306

3.  Developmental course of impulsivity and capability from age 10 to age 25 as related to trajectory of suicide attempt in a community cohort.

Authors:  Stephanie Kasen; Patricia Cohen; Henian Chen
Journal:  Suicide Life Threat Behav       Date:  2011-02-22

4.  Psychosocial factors contributing to suicidal ideation in hospitalized schizophrenia patients in Korea.

Authors:  Sung-Wan Kim; Su-Jung Kim; Ji-Woong Mun; Kyung-Yeol Bae; Jae-Min Kim; Seon-Young Kim; Su-Jin Yang; Il-Seon Shin; Jin-Sang Yoon
Journal:  Psychiatry Investig       Date:  2010-05-04       Impact factor: 2.505

5.  Prevalence and risk factors for suicidal behavior in young people presenting with first-episode psychosis in Hong Kong: a 3-year follow-up study.

Authors:  Wing Chung Chang; Emily S M Chen; Christy L M Hui; Sherry K W Chan; Edwin Ho Ming Lee; Eric Y H Chen
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2014-08-13       Impact factor: 4.328

6.  Case-control study of the relationship of depressive symptoms to suicide in a community-based sample of individuals with schizophrenia in China.

Authors:  John Kasckow; Nancy Liu; Gretchen L Haas; Michael R Phillips
Journal:  Schizophr Res       Date:  2010-03-12       Impact factor: 4.939

7.  The phenomenology and clinical correlates of suicidal thoughts and behaviors in youth with autism spectrum disorders.

Authors:  Eric A Storch; Michael L Sulkowski; Josh Nadeau; Adam B Lewin; Elysse B Arnold; P Jane Mutch; Anna M Jones; Tanya K Murphy
Journal:  J Autism Dev Disord       Date:  2013-10

8.  Social behavior, interaction appraisals, and suicidal ideation in schizophrenia: The dangers of being alone.

Authors:  Colin A Depp; Raeanne C Moore; Dimitri Perivoliotis; Jason L Holden; Joel Swendsen; Eric L Granholm
Journal:  Schizophr Res       Date:  2016-04       Impact factor: 4.939

9.  Predictors of Lifetime Suicide Attempts in Individuals With Attenuated Psychosis Syndrome.

Authors:  Zachary D Zuschlag; Jeffrey E Korte; Mark Hamner
Journal:  J Psychiatr Pract       Date:  2018-05       Impact factor: 1.325

10.  A potential role for adjunctive omega-3 polyunsaturated fatty acids for depression and anxiety symptoms in recent onset psychosis: Results from a 16 week randomized placebo-controlled trial for participants concurrently treated with risperidone.

Authors:  Delbert G Robinson; Juan A Gallego; Majnu John; Lauren A Hanna; Jian-Ping Zhang; Michael L Birnbaum; Jessica Greenberg; Melissa Naraine; Bart D Peters; Robert K McNamara; Anil K Malhotra; Philip R Szeszko
Journal:  Schizophr Res       Date:  2018-09-19       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.